Organon International
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Organon is a pharmaceutical company headquartered in Roseland, New Jersey that is part of Akzo Nobel.
Organon deals in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, HRT and anesthesia. Organon sells to international markets.
Organon was founded by Dr.Saal van Zwanenberg in Oss, the Netherlands, in 1923 as Zwanenberg-Organon. Its first product was insulin. In the thirties it manufactured estrogens. The production of cortison was initiated in 1953. The now named Koninklijke Zwanenberg-Organon (KZO) fused with the fiber producer AKU in 1969 to become AKZO, later Akzo Nobel. Organon is the human health care business unit of Akzo Nobel and transferred its headquarters to the USA while the main headquarter of Akzo Nobel remains in Arnhem. Manufacturing facilities are in the Netherlands, Germany, the United Kingdom, China, Japan, and the USA.
Products include: Remeron, Remeron SolTab, Sustanon, Deca-Durabolin, Pregnyl and a variety of other contraceptive products.
As of March 12, 2007, Organon BioSciences N.V. has been acquired by Schering Plough [1].
References
1. "Schering-Plough to Acquire Organon BioSciences,"
External links
de:Organon (Pharma) fr:Organon BioSciences nl:Organon (multinational)
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
